2025-08-29 03:24:05
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Coral Laboratories Ltd Q4 FY2022-23 loss at Rs. 89.22 lakhs
Posted On : 2023-05-23 19:08:54( TIMEZONE : IST )
CORAL LABORATORIES LTD. has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 12.5991 crores during the period ended March 31, 2023 as compared to Rs. 26.2271 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. -0.8922 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 0.8575 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. -2.50 for the period ended March 31, 2023 as compared to Rs. 2.40 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹12.5991 crs | ₹26.2271 crs |  -51.96% |
| Net Profit | ₹-0.8922 crs | ₹0.8575 crs | -204.05% |
| EPS | ₹-2.50 | ₹2.40 | -204.17% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.12.5991 crores during the period ended March 31, 2023 as compared to Rs.21.6055 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-0.8922 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.2.5464 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.-2.50 for the period ended March 31, 2023 as compared to Rs.7.13 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹12.5991 crs | ₹21.6055 crs | -41.69% |
| Net Profit | ₹-0.8922 crs | ₹2.5464 crs | -135.04% |
| EPS | ₹-2.50 | ₹7.13 | -135.06% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.85.0135 crores during the Financial Year ended March 31, 2023 as compared to Rs.80.4244 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.6.4454 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.9.0457 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.18.04 for the Financial Year ended March 31, 2023 as compared to Rs.25.32 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹85.0135 crs | ₹80.4244 crs |  5.71% |
| Net Profit | ₹6.4454 crs | ₹9.0457 crs | -28.75% |
| EPS | ₹18.04 | ₹25.32 | -28.75% |
Shares of CORAL LABORATORIES LTD. was last trading in BSE at Rs. 252.15 as compared to the previous close of Rs. 279.90. The total number of shares traded during the day was 8571 in over 92 trades.
The stock hit an intraday high of Rs. 280.00 and intraday low of 241.20. The net turnover during the day was Rs. 2169177.00.
